Kenley K. Hoover Email & Phone Number

Sweeping patent reform and case law developments have fundamentally changed the best strategies for creating, protecting and leveraging the intellectual property that accounts for as much as 84% of the value of most companies. It is therefore critically important that existing IP strategies are reassessed and realigned to best position companies for achieving their business objectives and to avoid the pitfalls associated with conducting business as usual under the new IP regime.I've created more than 1 billion dollars in IP assets during my nearly 20 years of legal practice and I've gleaned a unique firsthand knowledge and understanding of the business and competitive factors that influence the priorities and bottom line of a company.My business-oriented IP counsel is founded in extensive IP knowledge and experience gained from creating, managing, directing and leveraging large and diverse multinational patent portfolios and IP assets, and prosecuting more than 500 U.S. patents to issuance.My clients have found my unique blend of legal (IP and corporate), business, technical (8 years post-graduate, 11 years in industry) and industry expertise to be particularly valuable in providing creative, insightful and cost-effective guidance relating to, for example: • designing and implementing strategies for identifying, creating, managing and leveraging IP assets;• providing counsel on IP matters relating to all aspects of drug discovery and development;• charting and navigating IP competitive landscapes; and • evaluating, licensing and acquiring IP.If you're tired of ineffective IP counsel or just simply want to realize greater value from your IP, I'd love to hear from you.All the best,KenleyDue Diligence, IP Valuation, Interferences, IPRs, Licensing, Opinions, Patent Prosecution, Product Lifecycle Management, Strategic IP Advice, Biotech., Chemical, Pharmaceuticals, Antibodies, Oligonucleotides, Aternative Scaffolds, Nanotech.

Listed skills include Patent Prosecution, Licensing, Biotechnology, Intellectual Property, and 9 others.